Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Gold and Silver: Capitulation Time

"People everywhere are being fed propaganda, lies and false stimuli of all kinds, but deep in their hearts, deep in their instincts, they know something is wrong."—G. Edward Griffin, author of The Creature from Jekyll Island My usual weekend missive was mildly delay...
Streetwise Reports | November 13, 2019 |

The Case for Buying Precious Metals

Maurice Jackson of Proven and Probable speaks with Andy Schectman, president of Miles Franklin Precious Metals Investments, about the rationale for buying precious metals and the best values at this time. Maurice Jackson: Joining us for a conversation is And...
Streetwise Reports | February 6, 2020 |

Global Insanity Prevails

"Destroyers seize gold and leave to its owners a counterfeit pile of paper." —Ayn Rand Why don't we start things off a tad differently this evening? Let me relate to you all a parable from the Book of Quantitative Easing where all is good and noble in the world of gov...
Streetwise Reports | September 16, 2019 |

Biotech to Launch Preclinical Studies of Antibody in Eight Cancer Types

This company's new trials, preferred dosing and upcoming biologics license application submission are discussed in an H.C. Wainwright & Co. report. In a Feb. 20 research note, H.C. Wainwright & Co. analyst Ram Selvaraju reported that CytoDyn Inc. (CYDY:OTCQB) plans to...
Streetwise Reports | March 1, 2019 |

Financial Crisis 2008: Is the Story Going to Repeat?

The coming year has the potential for a combination of major risks to the global economy coming together to cause a financial crisis rivaling that of 2008-09. The mortgage bubble that burst in 2008 led to multiple failures of financial institutions, major downturns in global...
Carl Cotton | March 15, 2019 |

We Should Let the Banks Burn Down

Bob Moriarty of 321 Gold explains why he believes banks should be allowed to fail. In later 2008 during what is now referred to as the Great Financial Crisis, government and financial managers had an opportunity to reset a badly out of balance banking system....
Streetwise Reports | August 7, 2019 |

NCI Chooses Veterinary Biopharma as Select Manufacturing Contractor

The contract's meaning, terms and benefits and the California firm's near-term catalysts are discussed in an H.C. Wainwright & Co. report. In a Sept. 12 research note, H.C. Wainwright & Co. analyst Swayampakula Ramakanth reported that Kindred Biosciences Inc. (KIN:NA...
Streetwise Reports | September 19, 2019 |

Cryptocurrency A New Beginning in the Offing

Whenever someone says the word cryptocurrency, the first thing that comes to the mind is Bitcoin. This virtual token of currency became all the more famous when its value rose to $20,000 in December 2017. However, after that Bitcoin saw a huge crash and its value decrease...
Ved Prakash | February 22, 2019 |

Electric Vehicle Sales Are Surging. Can Mineral Producers Meet Future Demand?

Elon Musk isn’t known for playing by the rules. The 48-year-old tech billionaire got himself into hot water with regulators a couple of years ago by tweeting that he was “considering taking Tesla private at $420. Funding secured.&CloseCurlyDoubleQuot...
Frank Holmes | May 14, 2020 |

Biotech to Test Stem Cell Product in COVID-19-Caused Acute Respiratory Distress

A description of Mesoblast's multi-site clinical trial and possible implication for the therapeutic are provided in an H.C. Wainwright & Co. report. In an April 9 research note, H.C. Wainwright & Co. analyst Swayampakula Ramakanth reported that Mesoblast Lt...
Streetwise Reports | April 16, 2020 |
1 2 3